Private Capital Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$9K Buy
225
+9
+4% +$481 0.01% 1070
2022
Q1
$15K Buy
216
+73
+51% +$5.34K ﹤0.01% 1123
2021
Q4
$11K Sell
143
-46
-24% -$4.06K ﹤0.01% 1258
2021
Q3
$18K Sell
189
-11
-6% -$1.16K ﹤0.01% 1121
2021
Q2
$25K Buy
200
+19
+10% +$2.27K 0.01% 970
2021
Q1
$24K Buy
181
+44
+32% +$6.02K 0.01% 971
2020
Q4
$18K Buy
137
+38
+38% +$4.59K ﹤0.01% 1222
2020
Q3
$10K Sell
99
-6
-6% -$518 ﹤0.01% 1323
2020
Q2
$9K Buy
105
+18
+21% +$1.44K ﹤0.01% 1368
2020
Q1
$5K Sell
87
-102
-54% -$8.28K ﹤0.01% 1479
2019
Q4
$17K Buy
189
+107
+130% +$9.41K ﹤0.01% 1162
2019
Q3
$7K Sell
82
-31
-27% -$3.53K ﹤0.01% 1565
2019
Q2
$7K Buy
113
+28
+33% +$2.82K ﹤0.01% 1529
2019
Q1
$7K Sell
85
-1
-1% -$85 ﹤0.01% 1568
2018
Q4
$5K Sell
86
-27
-24% -$1.85K ﹤0.01% 1609
2018
Q3
$8K Hold
113
﹤0.01% 1541
2018
Q2
$6K Buy
113
+30
+36% +$1.61K ﹤0.01% 1603
2018
Q1
$3K Sell
83
-585
-88% -$28.5K ﹤0.01% 1746
2017
Q4
$4 Buy
+668
New +$35.7K ﹤0.01% 1690

Other funds holding EXAS

Private Capital Group's EXAS Position: Q2 2022 in Review

Private Capital Group increased its Exact Sciences (EXAS) stake by 4.2% in Q2 2022, buying an estimated $481 and bringing the position to 225 shares worth $9K. The position accounts for 0.01% of the portfolio, ranked #1070.

Private Capital Group first reported a position in EXAS in Q4 2017 and has held it in 19 quarters since. The position peaked at $25K in Q2 2021. 501 funds tracked by Wall St. Rank hold EXAS as of Q2 2022.

  • Private Capital Group held 225 shares of Exact Sciences worth $9K as of Q2 2022.
  • Private Capital Group bought 9 Exact Sciences shares in Q2 2022, an estimated $481.
  • Exact Sciences made up 0.01% of Private Capital Group's portfolio in Q2 2022, its #1070 holding.
  • Private Capital Group first reported a position in Exact Sciences in Q4 2017 and has held it in 19 quarters since.
  • Private Capital Group's Exact Sciences position peaked at $25K in Q2 2021.
  • 501 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.